Antimicrobial susceptibility testing (AST) is a critical function of the clinical microbiology
laboratory and is essential for optimizing care of patients with infectious diseases …

Background To evaluate the clinical features of patients with Acinetobacter baumannii
bloodstream infection (BSI). Methods Totally 200 inpatients with Acinetobacter baumannii …

Timely administration of appropriate antibiotic therapy is associated with better patient
outcomes and lower costs of care compared to delayed appropriate therapy, yet initial …

Importance Initiating effective therapy early is associated with improved survival among
patients hospitalized with gram-negative bloodstream infections; furthermore, providing …

Tetracycline-based combinations are increasingly used for serious carbapenem-
nonsusceptible Acinetobacter baumannii (CNSAb) infections given their potent in vitro …

This study aims to determine the characteristics and distribution of pathogenic bacteria in
bloodstream infections (BSIs) by gram-negative bacteria in adults. One hundred seventy …

Background Ceftolozane/tazobactam and ceftazidime/avibactam are commonly used in
patients with MDR-Pseudomonas aeruginosa (PSA) pneumonia (PNA). This study …

Background Antimicrobial susceptibility testing (AST) is often needed prior to antimicrobial
optimization for patients with gram-negative bloodstream infections (GN-BSIs). Rapid AST …

Objectives The early initiation of the empirical antibiotic treatment and its impact on mortality
in patients with bacteraemia has been extensively studied. However, information on the …

Purpose In view of the fact that Acinetobacter baumannii bloodstream infection (BSI) is a
great threat to human survival, early identification of the risk factors affecting prognosis will …